The fact that phosphorylation of Akt proteins was more effectively inhibited by the CCR4 antagonist than by the CCR2 antagonist also indicates the efficiency of CCR4 in prostate cancer migration and invasion. The gene discussed is AKT1; the disease is prostate carcinoma.